Catheter ablation versus antiarrhythmic drugs as first-line therapy for symptomatic atrial fibrillation: a systematic review and meta-analysis

Back

EHRA Premium Access

Catheter ablation versus antiarrhythmic drugs as first-line therapy for symptomatic atrial fibrillation: a systematic review and meta-analysis

Session: ePoster session

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor M. Casula (Cagliari, IT)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Matteo Casula

AO Brotzu Hospital, Cagliari (Italy)

1 presentation

0 follower

286 more presentations in this session

Non-valvular atrial fibrillation recurrence after sinus rhythm restoring at different follow-up periods: phenotype-genotype high-risk groups, considering rs10465885 polymorphism in connexin-40 gene

Speaker: Doctor T. Mikhalieva (Kyiv, UA)

Access

Abstract

Slides

Atrial fibrillation substrate mapping with decrement evoked potential mapping.

Speaker: Doctor O. Salvador (Madrid, ES)

Access

Abstract

Slides

Atrial tissue characterization by cardiac magnetic resonance and high-density mapping in patients with atrial fibrillation

Speaker: Miss R. Adelino Recasens (Barcelona, ES)

Access

Abstract

Slides

Proarrhythmic atrial structural and molecular remodeling with advancing age. Implications for post-coronary artery bypass grafting atrial fibrillation occurrence.

Speaker: Doctor R. SERBAN (Targu Mures, RO)

Access

Abstract

Slides

Find me if you can: lessons learned using the novel cartofinder algorithm in a routine workflow for catheter ablation of atrial fibrillation

Speaker: Doctor C. Sohns (Bad Oeynhausen, DE)

Access

Abstract

Slides

Access the full session

ePoster session

Speakers: Doctor M. Casula, Doctor T. Mikhalieva, Doctor O. Salvador, Miss R. Adelino Recasens, Doctor R. SERBAN...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources